Residual lifetime risk of cardiovascular diseases in Japan

Tanvir Chowdhury Turin, Nahid Rumana, Tomonori Okamura

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Risk assessment of cardiovascular diseases (CVD) is shifting from the relative risk to an absolute risk approach. The residual lifetime risk (LTR), which provides an absolute risk assessment, is an epidemiologic measure that expresses the probability of someone of a given age and sex developing a disease condition during their remaining lifespan. The LTR estimation is important because it could be more easily comprehended by clinicians and patients. The LTR for CVD was not estimated for the Japanese population until recently, when the LTR of stroke and acute myocardial infarction (AMI) was reported. The reported LTR of stroke and AMI for middle-aged adults is substantial. The observed probabilities illustrated that approximately 1 in 5 men and women of middle age will suffer from a stroke in their remaining lifetime. On the other hand, approximately 1 in 6 men and 1 in 9 women of middle age will suffer from AMI in their remaining lifetime. Aaginst the backdrop of the aging population and worsening risk factor scenario, these estimates re-emphasize that CVD is a public health burden that requires preventive interventions. These estimates provide a means to communicate the absolute risk of CVD to the lay population, policy makers, as well as health service providers in predicting the disease burden of CVD. This easily comprehended knowledge can be used as an important index to assist in public health education and planning.

Original languageEnglish
Pages (from-to)443-447
Number of pages5
JournalJournal of Atherosclerosis and Thrombosis
Volume18
Issue number6
DOIs
Publication statusPublished - 2011

Fingerprint

Japan
Cardiovascular Diseases
Stroke
Myocardial Infarction
Public health
Risk assessment
Public Health
Health Planning
Public Policy
Administrative Personnel
Health Education
Population
Health Services
Aging of materials
Education
Health
Planning

Keywords

  • Acute myocardial infarction
  • Atherosclerotic cardiovascular diseases
  • Japan
  • Lifetime risk
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Biochemistry, medical

Cite this

Residual lifetime risk of cardiovascular diseases in Japan. / Turin, Tanvir Chowdhury; Rumana, Nahid; Okamura, Tomonori.

In: Journal of Atherosclerosis and Thrombosis, Vol. 18, No. 6, 2011, p. 443-447.

Research output: Contribution to journalArticle

Turin, Tanvir Chowdhury ; Rumana, Nahid ; Okamura, Tomonori. / Residual lifetime risk of cardiovascular diseases in Japan. In: Journal of Atherosclerosis and Thrombosis. 2011 ; Vol. 18, No. 6. pp. 443-447.
@article{a2ca441e83b34b2bab6e7e5a6d75f303,
title = "Residual lifetime risk of cardiovascular diseases in Japan",
abstract = "Risk assessment of cardiovascular diseases (CVD) is shifting from the relative risk to an absolute risk approach. The residual lifetime risk (LTR), which provides an absolute risk assessment, is an epidemiologic measure that expresses the probability of someone of a given age and sex developing a disease condition during their remaining lifespan. The LTR estimation is important because it could be more easily comprehended by clinicians and patients. The LTR for CVD was not estimated for the Japanese population until recently, when the LTR of stroke and acute myocardial infarction (AMI) was reported. The reported LTR of stroke and AMI for middle-aged adults is substantial. The observed probabilities illustrated that approximately 1 in 5 men and women of middle age will suffer from a stroke in their remaining lifetime. On the other hand, approximately 1 in 6 men and 1 in 9 women of middle age will suffer from AMI in their remaining lifetime. Aaginst the backdrop of the aging population and worsening risk factor scenario, these estimates re-emphasize that CVD is a public health burden that requires preventive interventions. These estimates provide a means to communicate the absolute risk of CVD to the lay population, policy makers, as well as health service providers in predicting the disease burden of CVD. This easily comprehended knowledge can be used as an important index to assist in public health education and planning.",
keywords = "Acute myocardial infarction, Atherosclerotic cardiovascular diseases, Japan, Lifetime risk, Stroke",
author = "Turin, {Tanvir Chowdhury} and Nahid Rumana and Tomonori Okamura",
year = "2011",
doi = "10.5551/jat.7500",
language = "English",
volume = "18",
pages = "443--447",
journal = "Journal of Atherosclerosis and Thrombosis",
issn = "1340-3478",
publisher = "Japan Atherosclerosis Society",
number = "6",

}

TY - JOUR

T1 - Residual lifetime risk of cardiovascular diseases in Japan

AU - Turin, Tanvir Chowdhury

AU - Rumana, Nahid

AU - Okamura, Tomonori

PY - 2011

Y1 - 2011

N2 - Risk assessment of cardiovascular diseases (CVD) is shifting from the relative risk to an absolute risk approach. The residual lifetime risk (LTR), which provides an absolute risk assessment, is an epidemiologic measure that expresses the probability of someone of a given age and sex developing a disease condition during their remaining lifespan. The LTR estimation is important because it could be more easily comprehended by clinicians and patients. The LTR for CVD was not estimated for the Japanese population until recently, when the LTR of stroke and acute myocardial infarction (AMI) was reported. The reported LTR of stroke and AMI for middle-aged adults is substantial. The observed probabilities illustrated that approximately 1 in 5 men and women of middle age will suffer from a stroke in their remaining lifetime. On the other hand, approximately 1 in 6 men and 1 in 9 women of middle age will suffer from AMI in their remaining lifetime. Aaginst the backdrop of the aging population and worsening risk factor scenario, these estimates re-emphasize that CVD is a public health burden that requires preventive interventions. These estimates provide a means to communicate the absolute risk of CVD to the lay population, policy makers, as well as health service providers in predicting the disease burden of CVD. This easily comprehended knowledge can be used as an important index to assist in public health education and planning.

AB - Risk assessment of cardiovascular diseases (CVD) is shifting from the relative risk to an absolute risk approach. The residual lifetime risk (LTR), which provides an absolute risk assessment, is an epidemiologic measure that expresses the probability of someone of a given age and sex developing a disease condition during their remaining lifespan. The LTR estimation is important because it could be more easily comprehended by clinicians and patients. The LTR for CVD was not estimated for the Japanese population until recently, when the LTR of stroke and acute myocardial infarction (AMI) was reported. The reported LTR of stroke and AMI for middle-aged adults is substantial. The observed probabilities illustrated that approximately 1 in 5 men and women of middle age will suffer from a stroke in their remaining lifetime. On the other hand, approximately 1 in 6 men and 1 in 9 women of middle age will suffer from AMI in their remaining lifetime. Aaginst the backdrop of the aging population and worsening risk factor scenario, these estimates re-emphasize that CVD is a public health burden that requires preventive interventions. These estimates provide a means to communicate the absolute risk of CVD to the lay population, policy makers, as well as health service providers in predicting the disease burden of CVD. This easily comprehended knowledge can be used as an important index to assist in public health education and planning.

KW - Acute myocardial infarction

KW - Atherosclerotic cardiovascular diseases

KW - Japan

KW - Lifetime risk

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=79959859727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959859727&partnerID=8YFLogxK

U2 - 10.5551/jat.7500

DO - 10.5551/jat.7500

M3 - Article

VL - 18

SP - 443

EP - 447

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

SN - 1340-3478

IS - 6

ER -